company background image
MANKIND logo

Mankind Pharma NSEI:MANKIND Stock Report

Last Price

₹2.08k

Market Cap

₹833.8b

7D

-1.6%

1Y

8.5%

Updated

23 Jul, 2024

Data

Company Financials +

Mankind Pharma Limited

NSEI:MANKIND Stock Report

Market Cap: ₹833.8b

MANKIND Stock Overview

Develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally.

MANKIND fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance6/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for MANKIND from our risk checks.

Mankind Pharma Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Mankind Pharma
Historical stock prices
Current Share Price₹2,081.20
52 Week High₹2,490.00
52 Week Low₹1,683.05
Beta0
11 Month Change-3.93%
3 Month Change-13.22%
1 Year Change8.48%
33 Year Changen/a
5 Year Changen/a
Change since IPO46.33%

Recent News & Updates

Risks To Shareholder Returns Are Elevated At These Prices For Mankind Pharma Limited (NSE:MANKIND)

Jul 12
Risks To Shareholder Returns Are Elevated At These Prices For Mankind Pharma Limited (NSE:MANKIND)

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For Mankind Pharma Limited (NSE:MANKIND)

Jul 12
Risks To Shareholder Returns Are Elevated At These Prices For Mankind Pharma Limited (NSE:MANKIND)

Here's Why Mankind Pharma (NSE:MANKIND) Has Caught The Eye Of Investors

May 08
Here's Why Mankind Pharma (NSE:MANKIND) Has Caught The Eye Of Investors

Mankind Pharma Limited's (NSE:MANKIND) Business Is Trailing The Market But Its Shares Aren't

Apr 08
Mankind Pharma Limited's (NSE:MANKIND) Business Is Trailing The Market But Its Shares Aren't

Mankind Pharma Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 04
Mankind Pharma Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Shareholder Returns

MANKINDIN PharmaceuticalsIN Market
7D-1.6%-0.6%-1.5%
1Y8.5%47.4%43.8%

Return vs Industry: MANKIND underperformed the Indian Pharmaceuticals industry which returned 47.4% over the past year.

Return vs Market: MANKIND underperformed the Indian Market which returned 43.8% over the past year.

Price Volatility

Is MANKIND's price volatile compared to industry and market?
MANKIND volatility
MANKIND Average Weekly Movement3.6%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.2%

Stable Share Price: MANKIND has not had significant price volatility in the past 3 months.

Volatility Over Time: MANKIND's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198619,540Sheetal Arorawww.mankindpharma.com

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations.

Mankind Pharma Limited Fundamentals Summary

How do Mankind Pharma's earnings and revenue compare to its market cap?
MANKIND fundamental statistics
Market cap₹833.80b
Earnings (TTM)₹19.13b
Revenue (TTM)₹103.35b

43.6x

P/E Ratio

8.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MANKIND income statement (TTM)
Revenue₹103.35b
Cost of Revenue₹33.21b
Gross Profit₹70.14b
Other Expenses₹51.01b
Earnings₹19.13b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 31, 2024

Earnings per share (EPS)47.75
Gross Margin67.87%
Net Profit Margin18.51%
Debt/Equity Ratio2.0%

How did MANKIND perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.